Gerresheimer's Financial Crisis Deepens Amid Accounting Scandal and Asset Sale

Gerresheimer misses financial filing deadline, triggering asset sales and a widened BaFin investigation. Share price plummets amid €240M potential impairments and indefinite report delays.

The situation at packaging specialist Gerresheimer has deteriorated further after the company missed a crucial deadline. The firm failed to submit its audited 2025 annual financial statements by the March 31 cutoff, prolonging a period of severe uncertainty for shareholders. Management actions have only compounded the issue, triggering a cascade of postponed events and forcing a fire sale of assets to stay afloat.

Liquidity Crisis Forces Drastic Measures

Facing a fundamental liquidity crunch, Gerresheimer's leadership is taking severe action. In a move to secure its financial survival, the company has put its profitable US subsidiary, Centor, up for sale. Investment bank Morgan Stanley is managing the divestment process, which aims to inject urgently needed capital. Furthermore, the group will shutter its Chicago Heights glass plant by the end of 2026, shifting production to facilities in Italy and India. These steps are deemed essential to strengthen the company's negotiating hand with creditor banks regarding the extension of strict loan covenants.

Expanding Regulatory Scrutiny and Mounting Losses

Parallel to the internal turmoil, Germany's financial regulator, BaFin, has significantly widened its investigation. Initially focused on irregularities in revenue recognition, the probe now examines several other critical balance sheet items:

• Incorrectly reported lease liabilities totaling approximately €65.5 million.
• Capitalized development costs carrying a book value of €29.4 million.
• Potential unimpaired write-downs in the Advanced Technologies segment that could reach up to €196.5 million.

Given the scale of these issues, the market is now factoring in non-cash impairment charges that could total as much as €240 million.

Market Reaction and a Paralyzed Calendar

The persistent lack of transparency continues to erode investor confidence. The stock fell another 3.63% in today's trading, dropping to €19.12. This decline brings the total loss over the past twelve months to a devastating 72.15%.

The absence of the certified annual report has completely derailed the company's financial calendar. Gerresheimer has indefinitely postponed both the Q1 2026 quarterly report and its Annual General Meeting, which was scheduled for June. Management now targets June at the earliest for releasing a new, audited set of financials.

Under these circumstances, a sustainable recovery in the share price appears virtually impossible. Until the company publishes its certified statements and reaches a viable agreement with its lending banks, investors are effectively operating in the dark. The extreme downside risk will persist until the final magnitude of the required accounting adjustments is definitively known.